Creatine & Phosphocreatine System

Navigation

Upward Index: 02 - Compounds & Molecules MOC | Literature Dossier: Creatine & Phosphocreatine System - References

---

1. Pharmacodynamics & Mechanism of Action

Creatine ($N$-aminoiminomethyl-$N$-methylglycine) is a nitrogenous organic acid critical for spatial and temporal energy buffering in high-ATP-turnover tissues (skeletal muscle, myocardium, brain, and retina).

• The Phosphagen Shuttle (Creatine Kinase Reaction): Cytosolic and mitochondrial Creatine Kinase (CK) isoenzymes catalyze the reversible transfer of an $N$-phosphoryl group from Phosphocreatine (PCr) to $\text{ADP}$: $\text{PCr}+{\text{Mg-ADP}}^{-}+{\text{H}}^{+}\stackrel{\text{Creatine Kinase}}{\leftrightarrow }\text{Creatine}+{\text{Mg-ATP}}^{2-}$ This reaction occurs $10\times$ faster than glycolysis and $70\times$ faster than oxidative phosphorylation, consuming ${\text{H}}^{+}$ protons (buffering intracellular acidosis) and preventing $\text{AMP}$ accumulation.
• Cerebral Bioenergetics & Sleep Deprivation Resilience: The human brain accounts for $20\%$ of resting metabolic expenditure. During acute sleep deprivation, hypoxia, or intense cognitive load, cerebral PCr stores drop precipitously. High-dose creatine ($10\text{–}20\text{ g}$) drives transport across the blood-brain barrier via SLC6A8 (CRT1) transporters on microvessel endothelial cells, preserving cerebral $\text{PCr/Pi}$ ratios and stabilizing cellular pH.
• Methylation Sparing (GAMT Inhibition): Endogenous synthesis of $1.5\text{–}2.0\text{ g/day}$ creatine from arginine and glycine via AGAT and Guanidinoacetate N-Methyltransferase (GAMT) consumes $\sim 40\%$ of total labile S-Adenosylmethionine (SAMe) methyl groups. Exogenous creatine feedback-inhibits AGAT expression, sparing SAMe for Methylation & B-Complex pathways (phosphatidylcholine and DNA methylation) and lowering plasma homocysteine.

---

2. Pharmacokinetics & Form Comparison

• Creatine Monohydrate (Micronized / Creapure): $>99\%$ oral bioavailability; absorbed intact across the jejunum via sodium-chloride-dependent SLC6A8 transporters ($T_{\max }\approx 60\text{–}90\text{ min}$, plasma $t_{1/2}\approx 3\text{ hours}$).
• Muscle vs. Brain Saturation Kinetics:
  • Skeletal Muscle: High density of sarcolemmal SLC6A8 and insulin-sensitive uptake allows $3\text{–}5\text{ g/day}$ to elevate intramuscular total creatine ($\text{Cr}+\text{PCr}$) by $+20\text{–}40\%$ within 28 days (or 5–7 days at $20\text{ g/day}$).
  • Central Nervous System: Astrocytes covering BBB capillaries lack robust SLC6A8 expression, limiting passive cerebral influx. Elevating brain creatine by $+5\text{–}15\%$ (measured via ${}^{31}\text{P-MRS}$ or ${}^1\text{H-MRS}$) typically requires $10\text{–}20\text{ g/day}$ or chronic extended dosing.
• Alternative Salts (HCl, Ethyl Ester, Buffered): No alternative form has outperformed Creatine Monohydrate in human muscle biopsy trials; Creatine Ethyl Ester (CEE) rapidly degrades into inactive creatinine in gastric acid.

---

3. Dosing, Cycling & Synergies

• Standard Protocol:
  • Baseline / Musculoskeletal & Methylation: $5\text{ g/day}$ ($0.07\text{ g/kg/day}$) Micronized Creatine Monohydrate continuously.
  • Chronic Brain Saturation: $10\text{ g/day}$ split into two $5\text{ g}$ doses (AM and PM).
  • Acute Sleep Deprivation / Jet Lag Rescue: $0.35\text{ g/kg}$ ($20\text{–}25\text{ g}$) divided over 3–4 hours during acute sleep restriction.
• Cycling Cadence: Do not cycle; exogenous supplementation does not permanently downregulate endogenous AGAT/GAMT synthesis upon cessation.
• Synergies: Magnesium Forms & Bioavailability (${\text{Mg}}^{2+}$ stabilizes the $\text{ATP/ADP}$ complex for creatine kinase), Amino Acids & Precursors (Beta-Alanine/Carnosine for dual ${\text{H}}^{+}$ buffering), and D-Ribose / CoQ10.
• Contraindications & Biomarkers to Monitor:
  • Biomarker Confounder: Creatine non-enzymatically cyclizes into creatinine at $\sim 1.7\%/\text{day}$, falsely elevating serum creatinine and lowering creatinine-based eGFR calculations without true renal injury.
  • Biomarkers to Use: Always order Serum Cystatin C (and Cystatin C-based eGFR) to accurately evaluate glomerular filtration rate in individuals supplementing with creatine.

---

4. Key Scientific Evidence Summary

• ISSN Position Stand: Kreider et al. (2017) synthesized over 1,000 studies confirming that $3\text{–}5\text{ g/day}$ creatine monohydrate safely increases intramuscular phosphocreatine by $15\text{–}40\%$, enhances lean mass and power output by $5\text{–}15\%$, and shows no adverse renal or hepatic effects over multi-year trials.
• Acute Sleep Deprivation & Brain Bioenergetics: Gordji-Nejad et al. (2024) demonstrated in Scientific Reports using ${}^{31}\text{P-MRS}$ and ${}^1\text{H-MRS}$ that a single high dose ($0.35\text{ g/kg}$) of creatine during 21 hours of sleep deprivation prevented the decline in cerebral $\text{PCr/Pi}$ ratio, stabilized brain pH, and significantly enhanced processing speed and working memory.

See full study breakdowns in Creatine & Phosphocreatine System - References.